• No results found

The metabolic cost of lowering blood pressure with hydrochlorothiazide

N/A
N/A
Info
Download
Protected

Academic year: 2020

Share "The metabolic cost of lowering blood pressure with hydrochlorothiazide"

Copied!
7
0
0

Loading.... (view fulltext now)

Download now ( 7 Page )

Full text

Loading

Figure

Figure 1 Study consort diagram.
Table 1 Characteristics of study participants (mean ± standard error)
Figure 2 Impact of hydrochlorothiazide (HCTZ) and Valsartan treatments on hepatic triglyceride levels (hTG) and insulin sensitivity (SI).Results of hTG and SI are color coded relative to patient
Figure 3 (a) Changes in hepatic triglyceride content (hTG) aftertreatment with Valsartan and HCTZ ( p = 0.0098)

References

Download now ( PDF - 7 Page - 443.25 KB )

Related documents

Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial

Here, the safety and possible benefits of the nonselective β -blocker/vasodilator carvedilol were evaluated in a 6-month double-blind, placebo-controlled, randomized trial in

Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ

Combination angiotensin-receptor blocker (ARB)/calcium channel blocker with HCTZ vs the maximal recommended dose of an ARB with HCTZ in patients with stage 2 hypertension:

Evaluation of the Blood Pressure Lowering Effect of the Lactotripeptides Valine Proline Proline and Isoleucine Proline Proline in Non Hypertensive Japanese Subjects through a Meta Analysis of Randomized Controlled Studies

Inclusion criteria were as follows: randomized-controlled studies, with a single or double-blind design, in Japanese and non-HT (SBP lower than 140 mm Hg and diastolic blood pressure

A Human Atrial Natriuretic Peptide Gene Mutation Reveals a Novel Peptide With Enhanced Blood Pressure-Lowering, Renal-Enhancing, and Aldosterone-Suppressing Actions

In vivo with high-dose mANP (33 pmol/kg/min), we observed significantly greater plasma cGMP activation, diuretic, natri- uretic, glomerular filtration rate

Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials

The meta-analysis, based on evidence from 34 randomized double-blind placebo-controlled trials, showed a significant antihypertensive effect of Mg supplementation on both systolic and

Effects of multicomponent lifestyle modification on blood pressure control in health centers: Design of the study

The lifestyle modification trial is a multi‑center, double‑blind, randomized, controlled trial, designed to evaluate the effectiveness of a 4 week lifestyle intervention

Does Alpha‑lipoic Acid Supplement Regulate Blood Pressure? A Systematic Review of Randomized, Double‑blind Placebo‑controlled Clinical Trials

Finally, we selected nine articles, which had our inclusion criteria (randomized, double‑blind, placebo‑controlled clinical trials which investigated the effect of lipoic acid

Administration of Telmisartan Reduced Systolic Blood Pressure and Oxidative Stress Probably Through the Activation of PI3K/Akt/eNOS Pathway and NO Release in Spontaneously Hypertensive Rats

We investigated the effects of telmisartan, the blocker of angiotensin II receptor 1, on the regulation of systolic blood pressure (SBP) and oxidative stress through